Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

06/06/2022

B2RLaw advises Johnson Matthey Plc on GBP 50 million sale of its Battery Materials business

B2RLaw has advised Johnson Matthey Plc, a global leader in sustainable technologies, on all Polish aspects of its multijurisdictional sale […]

MORE
24/05/2022

B2RLaw as a partner of CEE VC Summit 2022

Together with Vestbee we would like to invite all startups and VC funds for the biggest event dedicated to VC […]

MORE
09/05/2022

B2RLaw commits to Greener Litigation

With a leading, and one of the largest disputes practices in Poland, B2RLaw is the first Polish law firm to […]

MORE
06/05/2022

B2RLaw advises Partners for Growth on multi-million USD international Venture Debt transaction

B2RLaw acted as Polish legal counsel to Partners for Growth (PFG) on its cross-border USD 25 million Venture Debt financing […]

MORE
26/04/2022

B2RLaw advises Fortress REIT on another logistics transaction regarding property in Zabrze

B2RLaw has advised South African-based Fortress REIT Limited on another logistics and warehousing acquisition, regarding property in the Silesia region […]

MORE
12/04/2022

B2RLaw recommended in the Legal500 ranking 2022

We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 5 […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close